Conference abstract · 25 Sep 2014
Conference abstractPublished 23 Nov 2012
Understanding facility validation for GMP compliance
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
In the past decade, many far-reaching changes have taken place in the application of cGMP regulations relating to the pharmaceutical industry. Continuous quality improvement thus is ingrained in the cGMP concept. The design, construction, commissioning, and validation of pharmaceutical facilities play very important role in the risk mitigation of product Quality and Safety. Among the six GMP systems of US FDA requirements for facility system are particularly important for pharmaceutical companies to understand and implement this GMP requirement therefore constructing new facilities and reconstructing the existing ones both require the compliance with the GMP. Facility qualification (a part of validation that proves and documents that equipment or ancillary systems are properly installed, work correctly, and actually lead to the expected results), and validation (establishing documented evidence that provides a high degree of assurance that the manufacturing processes, including buildings, systems, and equipment consistently produce the desired results according to predetermined specifications and quality attributes) activities will establish and provide documentary evidence that the facility suitable for the intended use for manufacturing, testing, storage meeting GMP requirements.
Subjects
Pharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Research article · Dec 2021
GMP Compliance for Sterile Drug Products: A Regulatory Prospectives
Conference abstract · 26 Oct 2015
Role of quality assurance in warehouse activities for the compliance of GMP
Conference abstract · 25 Sep 2014
GMP compliance for inspections, sampling and testing of packaging components in pharmaceuticals
Conference abstract · 23 Nov 2012
Overcoming the challenge of differing guidelines for compliance with GMP by different authorities
More from this journal
The newest in Pharmaceutical Regulatory Affairs: Open Access.
Article · 13 Feb 2026
Regulatory Scenario of Pharmaceuticals during COVID-19 Pandemic in India
Article · 11 Feb 2026
EU GMP Annex 1 of 2022: A View in Depth
Article · 11 Feb 2026
Standard Formats Used in Drug Regulatory Submissions and Software Used
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalPharmaceutical Regulatory Affairs: Open Access
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “J. Ramniwas”

